Skip to Main Content

Author Details

Katherine Lajkosz
Princess Margaret Hospital
2017
62
14
PMIDPaper TitleJournal TitlePublished Year
37696743Limitations of Prostate Biopsy in Detection of Cribriform and Intraductal Prostate Cancer.Eur Urol Focus2024
37558528Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools.Clin Genitourin Cancer2024
36486178Urinary complications after penile inversion vaginoplasty in transgender women Systematic review and meta-analysis.Can Urol Assoc J2023
37488332Surgical Site Infections During the Pandemic: The Impact of the "COVID Bundle".World J Surg2023
37747733APPRAISE-AI Tool for Quantitative Evaluation of AI Studies for Clinical Decision Support.JAMA Netw Open2023
37689547The Impact of CD34<sup>+</sup> Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma.Clin Lymphoma Myeloma Leuk2023
37541276Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed - Authors' reply.Lancet Oncol2023
37495897Intra-individual changes in sperm DNA fragmentation levels over short and long time periods.J Assist Reprod Genet2023
37494320Quantitative and qualitative impact of physician assistants in a Canadian urology setting.Can Urol Assoc J2023
37969774Improved sperm DNA fragmentation levels in infertile men following very short abstinence of 3-4 hours.Transl Androl Urol2023
35778618T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival.Skeletal Radiol2023
37187202Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.Lancet Oncol2023
37439809Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial.Clin Cancer Res2023
36702705Age related differences in primary testicular lymphoma: A population based cohort study.Urol Oncol2023
34672938Time trends of drug-specific actionable adverse events among patients on androgen receptor antagonists: Implications for remote monitoring.Can Urol Assoc J2022
35676330Impact of cribriform pattern 4 and intraductal prostatic carcinoma on National Comprehensive Cancer Network (NCCN) and Cancer of Prostate Risk Assessment (CAPRA) patient stratification.Mod Pathol2022
35506095Using health administrative data to identify patients with pulmonary hypertension: A single center, proof of concept validation study in Ontario, Canada.Pulm Circ2022
35537905Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes.Urol Oncol2022
35437219Variability in testosterone measurement between radioimmunoassay (RIA), chemiluminescence assay (CLIA) and liquid chromatography-tandem mass spectrometry (MS) among prostate cancer patients on androgen deprivation therapy (ADT).Urol Oncol2022
35534628Exploring the value of using patient-oriented MRI reports in clinical practice - a pilot study.Support Care Cancer2022
35852425Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men.Radiology2022
35596210Patient consent preferences on sharing personal health information during the COVID-19 pandemic: "the more informed we are, the more likely we are to help".BMC Med Ethics2022
35454861CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis.Cancers (Basel)2022
35393232The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancer.Urol Oncol2022
35622151Correction to: Exploring the value of using patientâ¿¿oriented MRI reports in clinical practice - a pilot study.Support Care Cancer2022
35811293Addition of Docetaxel to Androgen Receptor Axis-targeted Therapy and Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis.Eur Urol Oncol2022
36656705The rising burden of acute urological disease at an urban, academic hospital network.Can Urol Assoc J2022
36449294Statin Use and Survival Among Men Receiving Androgen-Ablative Therapies for Advanced Prostate Cancer: A Systematic Review and Meta-analysis.JAMA Netw Open2022
35905298The effect of lowering cholesterol through diet on serum prostate-specific antigen levels: A secondary analysis of clinical trials.Can Urol Assoc J2022
36230835Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular Stratification.Cancers (Basel)2022
35074179The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes.Pathology2022
34980879Have we mis-PRONOUNCEd the cardiovascular risk of GnRH agonists? A critical appraisal of the PRONOUNCE trial.Prostate Cancer Prostatic Dis2022
35170780Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume.Am J Hematol2022
33478752Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study.Gynecol Oncol2021
33495118Defining oligometastatic hormone sensitive prostate cancer and clinically significant outcomes: Implications on clinical trials?Urol Oncol2021
33761938The use of personal health information outside the circle of care: consent preferences of patients from an academic health care institution.BMC Med Ethics2021
33710797Population-based analysis of perioperative chemotherapy use, interventions requiring hospitalization and atheroembolic events among patients with non-metastatic muscle-invasive bladder cancer.Cancer Med2021
33502656Maximum plaque height in carotid ultrasound predicts cardiovascular disease outcomes: a population-based validation study of the American society of echocardiography's grade II-III plaque characterization and protocol.Int J Cardiovasc Imaging2021
34657655Prostatic urethral lift (UroLift) versus convective water vapor ablation (Rezum) for minimally invasive treatment of BPH: a comparison of improvements and durability in 3-year clinical outcomes.Can J Urol2021
34325919One size does not fit all: variations by ethnicity in demographic characteristics of men seeking fertility treatment across North America.Fertil Steril2021
34171210The impact of cannabis use on male sexual function: A 10-year, single-center experience.Can Urol Assoc J2021
34134928Characterization and management of NMIBC recurrences after TMT: a matched cohort analysis.Urol Oncol2021
31307272Management of Cancer-Associated Intestinal Obstruction in the Final Year of Life.J Palliat Care2020
34337460Salvage Radiotherapy Following Partial Gland Ablation for Prostate Cancer: Functional and Oncological Outcomes.Eur Urol Open Sci2020
33216888A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville score.Blood Adv2020
32712139Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of high-grade nonmuscle invasive bladder cancer after BCG failure.Urol Oncol2020
32386638Two Decades of Thoracic Empyema in Ontario, Canada.Chest2020
32458716Economic Burden and Healthcare Resource Use for Thoracic Aortic Dissections and Thoracic Aortic Aneurysms-A Population-Based Cost-of-Illness Analysis.J Am Heart Assoc2020
32156425Diagnosis and treatment of childhood intussusception from 1997 to 2016: A population-based study.J Pediatr Surg2020
30676852Patterns of Referral for Fertility Preservation Among Female Adolescents and Young Adults with Breast Cancer: A Population-Based Study.J Adolesc Young Adult Oncol2019
  • 1 - 50 of 62

Recommended Authors

David Geffen School of Medicine at university of california los angeles
Career Start Year 2019
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2017
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2015
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Institute of Health Policy
Career Start Year 2014
Number of shared co-authors 2
University of Texas Health San Antonio
Career Start Year 2013
Number of shared co-authors 0
University Hospitals Seidman Cancer Center, Case Western Reserve University
Career Start Year 2013
Number of shared co-authors 1
University of California Los Angeles
Career Start Year 2013
Number of shared co-authors 2
Center for Research on Health Care, University of Pittsburgh
Career Start Year 2012
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2012
Number of shared co-authors 0
University of North Carolina School of Medicine
Career Start Year 2012
Number of shared co-authors 2
Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 2011
Number of shared co-authors 0
university of california san diego School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Dell Medical School, The University of Texas at Austin
Career Start Year 2010
Number of shared co-authors 1
The Brady Urological Institute, Johns Hopkins Medicine
Career Start Year 2010
Number of shared co-authors 0
Brigham and Women's Hospital
Career Start Year 2010
Number of shared co-authors 0
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 3
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 1
University of North Carolina
Career Start Year 2008
Number of shared co-authors 0
University of Alberta
Career Start Year 2007
Number of shared co-authors 2
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 1
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 1
David Geffen School of Medicine at university of california los angeles
Career Start Year 2001
Number of shared co-authors 3
University of Washington School of Medicine
Career Start Year 2001
Number of shared co-authors 3
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 1
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 7
Rocky Mountain VA Medical Center
Career Start Year 1997
Number of shared co-authors 0
Queen's University
Career Start Year 1996
Number of shared co-authors 10
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 5

Collaborators

University of Toronto
Co-authored papers 18
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 10
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 8
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 7
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 7
University Health Network, University of Toronto
Co-authored papers 6
University of Toronto
Co-authored papers 4
University Health Network
Co-authored papers 4
University of Toronto
Co-authored papers 3
Mount Sinai Hospital, University of Toronto, University Health Network
Co-authored papers 3
University of Toronto
Co-authored papers 2
Princess Margaret Cancer Centre
Co-authored papers 2
Rollins School of Public Health, Emory University
Co-authored papers 1
Lions Gate Hospital
Co-authored papers 1
Erasmus MC Cancer Institute, University Medical Center
Co-authored papers 1
Mount Sinai Hospital
Co-authored papers 1
U-M Institute for Healthcare Policy and Innovation
Co-authored papers 1
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 1
New York Presbyterian Hospital-Weill Cornell
Co-authored papers 1
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
University of Montreal Health Center
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
Mayo Clinic College of Medicine
Co-authored papers 1
University of Toronto
Co-authored papers 1
University of Western Ontario
Co-authored papers 1
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
Westmead Hospital
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
University of Toronto
Co-authored papers 1